JSPR - Jasper Therapeutics Inc
1.38
0.010 0.725%
Share volume: 1,174,074
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.37
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-07-2024 | 02-28-2025 | 05-12-2025 | 11-10-2025 | |
| Assets | |||||||
| Total Assets | 125.963 M | 113.929 M | 99.413 M | 79.899 M | 57.597 M | 57.469 M | |
| Current Assets | 120.308 M | 108.680 M | 94.806 M | 75.811 M | 53.174 M | 54.564 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 118.475 M | 106.819 M | 92.502 M | 71.637 M | 48.799 M | 50.899 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 2.464 M | 2.438 M | 2.071 M | 1.875 M | 1.599 M | 1.102 M | |
| Other Assets | 2.774 M | 2.394 M | 2.536 M | 1.796 M | 2.407 M | 1.386 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 125.963 M | 113.929 M | 99.413 M | 79.899 M | 57.597 M | 57.469 M | |
| Total liabilities | 12.733 M | 13.619 M | 15.733 M | 18.225 M | 15.353 M | 45.898 M | |
| Total current liabilities | 8.916 M | 10.068 M | 12.459 M | 15.237 M | 12.334 M | 21.041 M | |
| Accounts Payable | 7.896 M | 9.019 M | 11.400 M | 14.148 M | 10.499 M | 19.338 M | |
| Other liabilities | 3.817 M | 3.551 M | 2.264 M | 2.988 M | 3.019 M | 24.857 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 3.817 M | 3.551 M | 2.264 M | 2.988 M | 3.019 M | 24.857 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 113.230 M | 100.310 M | 83.680 M | 61.674 M | 42.244 M | 11.571 M | |
| Common stock | 296.558 M | 298.221 M | 300.228 M | 302.543 M | 304.354 M | 319.140 M | |
| Retained earnings | -183.328 M | -197.911 M | -216.548 M | -240.869 M | -262.110 M | -307.569 M |